This session will bring together international experts to discuss the importance of accurate assays for diagnosing AQP4-NMOSD and MOGAD, explore regional assay availability, and share innovative approaches for sample testing and disease monitoring.
🕐 Agenda (60 minutes total):
Welcome and introduction – The importance of having accurate assays for the diagnosis of AQP4-NMOSD and MOGAD (2 min)
Sara Samadzadeh (Germany/Denmark)Current assays available for testing (assay availability survey) (10 min)
Patrick Waters (UK)Q&A – Regional perspectives on assay availability (8 min)
Adriana Casallas Vanegas (Colombia/Spain) & Sanja Glucevic (Montenegro)Sample types and testing approaches: CSF vs. serum for AQP4-NMOSD and MOGAD (10 min)
Sara Mariotto (Italy)Other approaches and experiences
Rapid IDOT – Rui Li (China) (10 min)
Dried blood spot testing for diagnosis and disease monitoring – Felix Wohlrab (Germany) (10 min)
Closing and wrap-up
📅 Date: Thursday, 27 November
🕙 Time: 10:00–11:00 CET (09:00–10:00 UK / 17:00–18:00 China)
🔗 Join via Microsoft Teams: https://teams.microsoft.com/meet/3296352538257?p=04EEPF2K5h2FVVH7cc